Evidence map›Paper›PMID 24778447›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

Cross-desensitization of CCR1, but not CCR2, following activation of the formyl peptide receptor FPR1.

Filip Bednar, Changcheng Song, Giuseppe Bardi, William Cornwell, Thomas J Rogers

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. TheFrontiers in immunology · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Circulating mitochondrialProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  7. Article
  8. Review
  9. Formyl peptide receptor 2 regulates monocyte recruitment to promote intestinal mucosal wound repair.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Filip BednarDepartment of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA 19140; and.
Changcheng SongCenter for Inflammation, Translational and Clinical Lung Research, Temple University School of Medicine, Philadelphia, PA 19140.
Giuseppe BardiCenter for Inflammation, Translational and Clinical Lung Research, Temple University School of Medicine, Philadelphia, PA 19140.
William CornwellCenter for Inflammation, Translational and Clinical Lung Research, Temple University School of Medicine, Philadelphia, PA 19140.
Thomas J RogersCenter for Inflammation, Translational and Clinical Lung Research, Temple University School of Medicine, Philadelphia, PA 19140 rogerst@temple.edu.
Temple University · US

Funding

Pilot Projects Core (PPC)P30DA013429 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI SCOTT M. RAWLS · 2000 to 2026
$34.6M
OPIOIDS IN AIDS PROGRESSION AND NEUROPATHOGENESIS OF SIV INFECTED MACAQUESP01DA023860 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI FISCHER, TRACY · 2008 to 2012
$7.0M
OPIOIDS, OPIOID RECEPTORS, AND IMMUNE COMPETENCER01DA006650 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI ADLER, MARTIN W · 1991 to 2012
$5.0M
Opioid &Chemokine Receptor Interactions Relative to HIVR01DA014230 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI ROGERS, THOMAS J · 2001 to 2016
$5.0M
Opioid Modulation of Inflammatory Monocyte Activity Involved in HIV SusceptibilitR01DA025532 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI ROGERS, THOMAS J · 2008 to 2012
$1.5M
Flourescence-Activated Cell SorterS10RR027910 · NCRR · TEMPLE UNIV OF THE COMMONWEALTH · PI ROGERS, THOMAS J · 2010 to 2010
$499k
NCRR NIH HHS S10 RR027910NIDA NIH HHS DA-06650NIDA NIH HHS DA-14230NIDA NIH HHS DA-25532NIDA NIH HHS P01 DA023860NIDA NIH HHS P01DA-23860NIDA NIH HHS P30 DA013429NIDA NIH HHS P30DA-13429NIDA NIH HHS R01 DA006650NIDA NIH HHS R01 DA014230NIDA NIH HHS R01 DA025532
6 · The paper itself

Abstract

The cross-regulation of G protein-coupled receptors (GPCRs) plays an important role in the immune response. Studies from several laboratories have suggested that a hierarchy of sensitivities to cross-desensitization exists for the chemoattractant GPCRs. We carried out experiments to study the capacity of the formyl peptide receptor-1 (FPR1) to desensitize chemokine receptors CCR1 and CCR2. Our results show that activation of FPR1 resulted in the desensitization and partial internalization of CCR1, but not CCR2, in both primary human monocytes and HEK293 cells coexpressing CCR1, CCR2, and FPR1 (HR1R2F cells). The desensitization of CCR1 by FPR1 stimulation was not due to the simple depletion of the Ca(2+) stores, but was dependent on activation of protein kinase C. Furthermore, we found that the cross-desensitization of CCR1 by FPR1 was associated with CCR1 phosphorylation and moderate reduction of CCR1 cell-surface expression. In contrast, CCR2 was not phosphorylated or internalized after FPR1 activation. Additional studies showed that optimal cross talk between FPR1 and CCR1 was dependent on the functional activity of protein kinase Cβ. These results provide a mechanistic basis for the capacity of certain GPCR ligands to exert rapid and selective cross-inactivation of other chemoattractant receptors, and suggest that FPR1 is able to exert "traffic control" in the migration of inflammatory cells by rapidly inhibiting the cell responses to potentially "low-priority" chemoattractants such as CCR1 agonists without inhibiting the response to "higher priority" CCR2 chemoattractants.

Indexed as

CalciumGene Expression RegulationHEK293 CellsHumansMonocytesProtein Kinase C betaReceptors, CCR1Receptors, CCR2Receptors, Formyl PeptideCalciumCCR1 protein, humanCCR2 protein, humanFPR1 protein, humanProtein Kinase C betaReceptors, CCR1Receptors, CCR2Receptors, Formyl Peptide

Identifiers

PMID24778447
PMCPMC4035699
OpenAlexW2143448489

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.